What is MindMaze?
Founded in 2012 and headquartered in Switzerland, MindMaze specializes in developing medical-grade virtual reality products designed to stimulate neural recovery. The company's core technology integrates VR, computer graphics, brain imaging, and neuroscience to create a platform for intuitive human-machine interfaces. This unique combination of disciplines positions MindMaze at the forefront of digital therapeutics and advanced neuro-rehabilitation solutions, addressing critical needs in patient care and recovery.
How much funding has MindMaze raised?
MindMaze has raised a total of $338.5M across 4 funding rounds:
Angel/Seed
$8.5M
Private Equity
$100M
Unspecified
$125M
Other Financing Round
$105M
Angel/Seed (2015): $8.5M, investors not publicly disclosed
Private Equity (2016): $100M led by Hinduja Group
Unspecified (2021): $125M supported by AlbaCore Capital
Other Financing Round (2022): $105M featuring AlbaCore Capital, Hambro Perks, and Concord Health Partners
Key Investors in MindMaze
AlbaCore Capital
AlbaCore Capital Group is a prominent European credit manager specializing in private credit and special situations investments, focusing on providing private capital solutions and direct lending.
Hambro Perks
Hambro Perks is a London-headquartered international investment firm focused on private technology investing, partnering with founders to support growth businesses.
Concord Health Partners
Concord Health Partners (CHP Merger Corp.) is a special purpose acquisition company focused on effecting a business combination within the healthcare sector.
What's next for MindMaze?
The substantial enterprise-level funding indicates MindMaze is poised for significant scaling and further innovation. This strategic investment will likely fuel the expansion of its product development pipeline, enhance its market penetration, and potentially support clinical trials or regulatory approvals for its advanced VR-based neural recovery systems. The company's focus on bridging neuroscience with cutting-edge technology suggests a future trajectory centered on broadening the application of its platform across various medical and potentially non-medical human-machine interface domains.
See full MindMaze company page
